Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.15%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 2.41Close
$ 2 - $ 2.7 52-Week Range
Ticker Information
Ticker
ORMPCompany Name
ORAMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQORAMED PHARMACEUTICALS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ORMP - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 143K | 7.15% | $ 2M |
| 3/31/2025 | $ 167K | 8.35% | $ 2M |
| 12/31/2024 | $ 193K | 0% | $ 0 |
| 9/30/2024 | $ 215K | 0% | $ 0 |
| 6/30/2024 | $ 217K | 0% | $ 0 |
| 3/31/2024 | $ 215K | 31.9% | $ 674K |
| 12/31/2023 | $ 196K | 14.63% | $ 1.34M |
| 9/30/2023 | $ 160K | 7.92% | $ 2.02M |
| 6/30/2023 | $ 121K | 4.48% | $ 2.7M |
| 3/31/2023 | $ 84K | 3.11% | $ 2.7M |
Key Performance Insights, Last 5 Years
- ORAMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) DepAmor % stands at 0.26%.
- Over the past 5 years, ORAMED PHARMACEUTICALS INC's average DepAmor % has been 6.12%.
- The median DepAmor % for ORAMED PHARMACEUTICALS INC during this period was 3.11%
- ORAMED PHARMACEUTICALS INC reached its highest DepAmor % over the past 5 years at 31.9%.
- The lowest DepAmor % recorded by ORAMED PHARMACEUTICALS INC in the same timeframe 0.26%
ORAMED PHARMACEUTICALS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for ORAMED PHARMACEUTICALS INC is calculated as follows: DepAmor [ $ 7K ] / Revenues [ $ 2.71M ]
(=) DepAmor % [ 0.26% ] ORMP - Depreciation and Amortization Margin, Last 5 years
0.26%
Minimum
Sep 30, 2020
31.9%
Maximum
Mar 31, 2024
6.12%
Average
3.11%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |